Carbidopa And Levodopa Capsule, Extended Release
Product Images NDC 70710-2140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 70710-2140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 01)

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 01)
Chemical structure depicting carbidopa monohydrate. The diagram shows the molecular arrangement of carbidopa with attached functional groups and a water molecule (H2O) indicating the monohydrate form.*
FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 02)

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 02)
Chemical structure diagram of Carbidopa showing a benzene ring with two hydroxyl groups, a side chain containing an amino group, and a carboxylic acid group.*
FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 23.75 mg/95 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 03)

Carbidopa And Levodopa Extended-release Capsules, 23.75 mg/95 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 03)
Label for Carbidopa and Levodopa Extended-Release Capsules with strength 23.75 mg/95 mg, supplied in a bottle of 100 capsules. The label shows the Zydus Pharmaceuticals USA Inc. logo and includes storage instructions, manufacturer and distributor information, and an NDC barcode.*
FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 36.25 mg/145 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 04)

Carbidopa And Levodopa Extended-release Capsules, 36.25 mg/145 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 04)
Label for Carbidopa and Levodopa Extended-Release Capsules 36.25 mg/145 mg by Zydus Pharmaceuticals USA Inc. The label indicates 100 capsules, prescription only, with storage and packaging instructions. Manufacturer is Bora Pharmaceutical Laboratories Inc., Taiwan, and the label includes an NDC barcode.*
FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 48.75 mg/195 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 05)

Carbidopa And Levodopa Extended-release Capsules, 48.75 mg/195 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 05)
Label for Carbidopa and Levodopa extended-release capsules, strength 48.75 mg/195 mg, in a package of 100 capsules. The label includes storage instructions, child safety warnings, and manufacturer information (Bora Pharmaceutical Laboratories Inc.) with distribution by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Carbidopa And Levodopa Extended-release Capsules, 61.25 mg/245 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 06)

Carbidopa And Levodopa Extended-release Capsules, 61.25 mg/245 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 06)
Label for Carbidopa and Levodopa Extended-Release Capsules, strength 61.25 mg/245 mg, presented in a package containing 100 capsules. The label indicates the product is prescription-only and manufactured by Bora Pharmaceutical Laboratories Inc., distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions and dosage guidance referencing the package insert, with a child-resistant designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.